Precision Biosciences (DTIL) Current Leases (2020 - 2025)
Historic Current Leases for Precision Biosciences (DTIL) over the last 6 years, with Q3 2025 value amounting to $1.5 million.
- Precision Biosciences' Current Leases rose 1435.29% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 1435.29%. This contributed to the annual value of $1.3 million for FY2024, which is 1650.49% up from last year.
- As of Q3 2025, Precision Biosciences' Current Leases stood at $1.5 million, which was up 1435.29% from $1.4 million recorded in Q2 2025.
- Over the past 5 years, Precision Biosciences' Current Leases peaked at $2.5 million during Q2 2023, and registered a low of $1.1 million during Q4 2023.
- Over the past 5 years, Precision Biosciences' median Current Leases value was $1.7 million (recorded in 2022), while the average stood at $1.7 million.
- Per our database at Business Quant, Precision Biosciences' Current Leases skyrocketed by 2968.34% in 2023 and then tumbled by 5106.04% in 2024.
- Over the past 5 years, Precision Biosciences' Current Leases (Quarter) stood at $1.8 million in 2021, then dropped by 7.9% to $1.7 million in 2022, then plummeted by 32.48% to $1.1 million in 2023, then rose by 16.5% to $1.3 million in 2024, then rose by 10.45% to $1.5 million in 2025.
- Its Current Leases stands at $1.5 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.4 million for Q1 2025.